By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ...
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to ...
Relayed: Cliff Richard issues plea to King Charles after revealing prostate cancer diagnosis Get the Well Enough newsletter with Harry Bullmore for tips on living a healthier, happier and longer life ...
More than 70% of patients with biochemically recurrent prostate cancer remained metastasis-free 5 years after PSMA PET/CT-guided salvage radiation therapy. Whole-pelvis radiation significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results